Cargando…
Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient Interviews
INTRODUCTION: We sought insights into the classification of and factors associated with relapse severity and disease stability in neuromyelitis optica spectrum disorder (NMOSD) clinical practice worldwide. METHODS: Neurologists recruited from six countries (the USA, Germany, Italy, Brazil, South Kor...
Autores principales: | Capobianco, Marco, Ringelstein, Marius, Welsh, Carly, Lobo, Patricia, deFiebre, Gabrielle, Lana-Peixoto, Marco, Wang, Jiawei, Min, Ju-Hong, Wingerchuk, Dean M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043113/ https://www.ncbi.nlm.nih.gov/pubmed/36826457 http://dx.doi.org/10.1007/s40120-022-00432-x |
Ejemplares similares
-
Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient Interviews
por: Min, Ju-Hong, et al.
Publicado: (2023) -
Eculizumab monotherapy for NMOSD: Data from PREVENT and its
open-label extension
por: Pittock, Sean J, et al.
Publicado: (2021) -
Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD
por: Wingerchuk, Dean M., et al.
Publicado: (2021) -
Sensitivity analysis of the primary endpoint from the N-MOmentum
study of inebilizumab in NMOSD
por: Cree, Bruce AC, et al.
Publicado: (2021) -
Adverse Events in NMOSD Therapy
por: Giglhuber, Katrin, et al.
Publicado: (2022)